These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 34326607)
21. COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023? Michalak A; Lach T; Szczygieł K; Cichoż-Lach H Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396888 [TBL] [Abstract][Full Text] [Related]
22. Outcomes of COVID-19 among patients with liver disease. Vujčić I World J Gastroenterol; 2023 Feb; 29(5):815-824. PubMed ID: 36816621 [TBL] [Abstract][Full Text] [Related]
23. COVID-19 and comorbidities of hepatic diseases in a global perspective. Ahmad A; Ishtiaq SM; Khan JA; Aslam R; Ali S; Arshad MI World J Gastroenterol; 2021 Apr; 27(13):1296-1310. PubMed ID: 33833483 [TBL] [Abstract][Full Text] [Related]
24. Acute-on-chronic liver failure by SARS-CoV-2 in active alcohol use disorder cirrhotic patient. Testino G; Pellicano R Minerva Gastroenterol (Torino); 2021 Sep; 67(3):283-288. PubMed ID: 33971711 [TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes. Baldelli L; Marjot T; Barnes E; Barritt AS; Webb GJ; Moon AM Gut Liver; 2023 Jan; 17(1):12-23. PubMed ID: 36457261 [TBL] [Abstract][Full Text] [Related]
30. Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients. Murray SM; Pose E; Wittner M; Londoño MC; Schaub G; Cook J; Dimitriadis S; Meacham G; Irwin S; Lim Z; Duengelhoef P; Sterneck M; Lohse AW; Perez V; Trivedi P; Bhandal K; Mullish BH; Manousou P; Provine NM; Avitabile E; Carroll M; Tipton T; Healy S; Burra P; Klenerman P; Dunachie S; Kronsteiner B; Maciola AK; Pasqual G; Hernandez-Gea V; Garcia-Pagan JC; Lampertico P; Iavarone M; Gines P; Lütgehetmann M; Schulze Zur Wiesch J; Russo FP; Barnes E; Marjot T; J Hepatol; 2024 Jan; 80(1):109-123. PubMed ID: 37863203 [TBL] [Abstract][Full Text] [Related]
31. Investigating the correlation between COVID-19 and the progression of chronic liver disease. Philips CA; Madhu D; Augustine P Expert Rev Gastroenterol Hepatol; 2023; 17(6):603-613. PubMed ID: 37086388 [TBL] [Abstract][Full Text] [Related]
32. Liver injury in the era of COVID-19. Cichoż-Lach H; Michalak A World J Gastroenterol; 2021 Feb; 27(5):377-390. PubMed ID: 33584070 [TBL] [Abstract][Full Text] [Related]
33. COVID-19 and the liver: A 2021 update. Spearman CW; Aghemo A; Valenti L; Sonderup MW Liver Int; 2021 Sep; 41(9):1988-1998. PubMed ID: 34152690 [TBL] [Abstract][Full Text] [Related]
34. Liver Injury and Dysfunction Associated with COVID-19: a Review Article. Yahia AIO Clin Lab; 2022 Jan; 68(1):. PubMed ID: 35023684 [TBL] [Abstract][Full Text] [Related]
38. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort. Yoo HW; Jin HY; Yon DK; Effenberger M; Shin YH; Kim SY; Yang JM; Kim MS; Koyanagi A; Jacob L; Smith L; Yoo IK; Shin JI; Lee SW J Korean Med Sci; 2021 Oct; 36(41):e291. PubMed ID: 34697932 [TBL] [Abstract][Full Text] [Related]
39. COVID-19 and the liver - Lessons learned. Herta T; Berg T Liver Int; 2021 Jun; 41 Suppl 1(Suppl 1):1-8. PubMed ID: 34155789 [TBL] [Abstract][Full Text] [Related]
40. Liver injury during highly pathogenic human coronavirus infections. Xu L; Liu J; Lu M; Yang D; Zheng X Liver Int; 2020 May; 40(5):998-1004. PubMed ID: 32170806 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]